Alert Mirati's Lung Cancer Drug Gets EU's Regulatory Backing Mirati Therapeutics said on Friday the European medicines regulator's panel has recommended approval of its treatment for a type of lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback